As per MRFR analysis, the South America Transarterial Chemoembolization Market Size was estimated at 570.07 (USD Million) in 2023. The South America Transarterial Chemoembolization Market Industry is expected to grow from 598(USD Million) in 2024 to 1,012.29 (USD Million) by 2035. The South America Transarterial Chemoembolization Market CAGR (growth rate) is expected to be around 4.902% during the forecast period (2025 - 2035).
Key South America Transarterial Chemoembolization Market Trends Highlighted
The South America Transarterial Chemoembolization (TACE) market is witnessing significant developments, primarily driven by increasing incidences of liver cancer and the demand for minimally invasive cancer treatment options. Countries like Brazil and Argentina are facing rising rates of liver illnesses attributable to factors such as Hepatitis infections and lifestyle changes, leading to higher healthcare expenditure on advanced treatment methods. Government initiatives focused on ramping up cancer treatment facilities and improving healthcare infrastructure in South America further enhance the demand for TACE procedures.
Recent trends show a growing acceptance of TACE as a standard treatment option among oncologists in the region, reflecting an increase in the number of trained professionals and advancements in medical technology.The TACE procedure has been rendered more precise as a result of the advancements in imaging techniques, which has created a more favourable environment for patients who are in search of effective treatments. It is worth noting that South American healthcare providers are increasingly collaborating with international medical institutions to ensure that their protocols are up-to-date and that the most recent techniques are implemented, resulting in improved patient outcomes.
Additionally, there are distinctive opportunities emerging in the South American TACE market, particularly in the area of research and development for novel embolic agents and drug formulations that can improve the efficacy of treatment strategies. The potential for innovation in TACE products is enhanced by the growing collaboration between global pharmaceutical companies and local medical associations.
Furthermore, the increasing awareness of patients regarding targeted cancer therapies has resulted in a significant shift towards personalised treatment plans that incorporate TACE in South America. This shift further confirms the healthy evolution of this specialised market segment.
 
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South America Transarterial Chemoembolization Market Drivers
Increasing Incidence of Liver Cancer
In recent years, the South America Transarterial Chemoembolization Market Industry has witnessed a noticeable increase in liver cancer cases. Statistics indicate that liver cancer was responsible for 9.2% of all cancer cases in South America in 2020, with an annual increase projected to reach approximately 15% by 2025. The Pan American Health Organization reported a significant spike in liver cancer cases, making it a critical health concern in several countries, including Brazil and Argentina.
This trend drives demand for advanced treatment options such as transarterial chemoembolization (TACE), as these methods offer localized treatment options with fewer systemic side effects. Improved awareness about liver health and the efficacy of TACE is likely to bolster patient and physician engagement, thereby accelerating market growth in the region. Major organizations like the Brazilian Society of Medical Oncology have actively promoted awareness programs, further boosting the adoption of TACE procedures.As the incidence of liver cancer is on the rise, healthcare providers are increasingly looking towards TACE as an effective treatment option, contributing positively to the South America Transarterial Chemoembolization Market.
Advancements in Medical Technology
Technological advancements play a pivotal role in the growth of the South America Transarterial Chemoembolization Market Industry. The introduction of state-of-the-art imaging techniques and catheter technologies has significantly improved the precision and safety of TACE procedures. For example, recent developments in digital subtraction angiography and real-time imaging allow better visualization of tumor vasculature, increasing the procedure's success rate.
Studies indicate that advanced imaging has improved outcomes in over 70% of cases involving liver tumors. Institutions such as the Latin American Society of Interventional Radiology are focusing on training healthcare professionals in these new technologies, thereby driving the adoption of TACE across the region. With improved technologies enhancing treatment efficacy and safety, the market is set for significant growth in the coming years.
Growing Investment in Healthcare Infrastructure
Increased government and private sector investment in healthcare infrastructure is a significant driver for the South America Transarterial Chemoembolization Market Industry. Reports suggest that the South American healthcare spending is projected to grow by 5% annually.
Specifically, Brazil announced a substantial increase in its healthcare budget focused on oncology treatments, which includes funding for interventional radiology services like TACE.The establishment of new oncology centers equipped with advanced technologies is increasingly seen across countries such as Chile and Colombia. These enhancements in healthcare infrastructure ensure that TACE procedures can be performed more efficiently and on a larger scale, thereby driving market growth. As more facilities adopt innovative cancer treatment methods, the South America Transarterial Chemoembolization Market stands to benefit from this upward trend in investment.
Rising Awareness and Usage of Minimally Invasive Procedures
The increasing awareness of minimally invasive medical procedures significantly influences the South America Transarterial Chemoembolization Market Industry. A recent survey indicated that approximately 65% of patients in Brazil prefer minimally invasive treatments due to shorter recovery times and reduced risk of complications. Organizations such as the Brazilian Society of Interventional Radiology are conducting seminars and campaigns to educate healthcare providers and patients on the advantages of techniques like TACE.
This focus on awareness is fostering a culture that favors innovative procedures, leading to an increase in the adoption of TACE therapies for cancer treatment. With the rising preference for less invasive options, the utilization of TACE is expected to grow, thereby propelling the overall market forward.
South America Transarterial Chemoembolization Market Segment Insights
Transarterial Chemoembolization Market Procedure Type Insights
The South America Transarterial Chemoembolization Market highlights significant trends under the Procedure Type segment, primarily focusing on Conventional TACE and DEB-TACE. Conventional TACE has been a widely accepted method for treating liver cancer, where chemotherapy is directly delivered to the tumor, combined with embolic agents to block blood flow, thus enhancing local drug concentration while minimizing systemic side effects. Its longstanding efficacy in managing hepatocellular carcinoma and metastatic liver disease ensures its continued relevance in clinical practice in South America.
Moreover, the adoption of DEB-TACE, which utilizes drug-eluting beads for a more targeted therapeutic approach, is gaining traction due to its ability to improve drug delivery and efficacy. This technique allows for less systemic exposure, potentially reducing toxicity and improving patient outcomes, making it an attractive option for healthcare practitioners. Both techniques have positioned themselves as critical options in the treatment hierarchy, addressing the regional burden of liver-related ailments. The increasing prevalence of liver disorders in South America, driven by lifestyle factors and rising rates of hepatitis infections, further fuels the demand for these procedures.
In this context, healthcare systems in South America are actively investing in advanced technology and training to enhance procedural outcomes, leading to an overall positive atmosphere for growth within the Transarterial Chemoembolization Market. As physicians and patients increasingly recognize the benefits of targeted therapies, the market for both Conventional TACE and DEB-TACE is expected to evolve, addressing unmet needs and enhancing treatment paradigms.
The interplay between these techniques illustrates the market dynamics, showcasing a growing preference for less invasive yet effective treatment methods in this region, emphasizing the need for continuous education and advancements in medical imaging and interventional radiology practices.Overall, the Procedure Type dimension of the South America Transarterial Chemoembolization Market exemplifies a responsive landscape, adapting to evolving patient needs and technological advancements in treating complex liver conditions.
 
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Transarterial Chemoembolization Market Indication Insights
The South America Transarterial Chemoembolization Market exhibits a notable focus on the Indication segment, which includes key areas such as Unresectable Hepatocellular Carcinoma (HCC) and Early-Stage HCC. The prevalence of liver cancer in South America has been on the rise, particularly in regions with higher rates of hepatitis B and C infections, emphasizing the significance of effective treatment options like transarterial chemoembolization. Unresectable HCC is particularly critical as it accounts for a substantial portion of liver cancer cases where surgical options are limited, thus driving the need for localized treatments that can manage tumor growth and improve patient outcomes.Early-Stage HCC, on the other hand, presents an opportunity for intervention that can lead to better prognosis and quality of life for patients.
Healthcare providers in South America are increasingly recognizing the importance of these indications, as they align with global shifts towards personalized and targeted cancer therapies. Moreover, the growing interest in research and development for advanced techniques in these indications signifies a forward-thinking approach within the healthcare community, aiming to enhance therapeutic efficacy while addressing the regional cancer burden more effectively.
Transarterial Chemoembolization Market Product Type Insights
The South America Transarterial Chemoembolization Market is characterized by its diverse range of product types, crucial in addressing various oncological needs across the region. Chemotherapeutic Agents stand out due to their effectiveness in delivering targeted drug therapy directly to tumors, enhancing treatment efficacy while minimizing systemic side effects. Radiotherapeutic Agents offer another critical avenue in the arsenal against cancer, providing localized radiation to eliminate malignant cells, thus playing a significant role in managing specific cancers prevalent in South America.
Additionally, Drug-eluting Particles have emerged as a vital innovation, allowing for the extended release of therapeutics within the tumor environment, which optimizes treatment outcomes and patient compliance. The "Others" category includes a range of emerging treatments and technologies that contribute to the landscape of transarterial chemoembolization, reflecting the ongoing research and development in the field. As the South American population faces a growing cancer burden driven by lifestyle changes and environmental factors, the importance of these product types cannot be overstated.
The market reflects a steady growth trajectory, encouraged by advancements in these therapeutic modalities, as healthcare systems in the region strive for improved cancer treatment options and outcomes. As such, each product type plays a significant role in the overall success of the South America Transarterial Chemoembolization Market, addressing both the immediate and long-term needs of patients across this diverse region.
Transarterial Chemoembolization Market End User Insights
The South America Transarterial Chemoembolization Market exhibits diverse dynamics within its End User segment, primarily comprising Hospitals and Clinics, Cancer Research Centers, and other healthcare facilities. Hospitals and Clinics represent a substantial portion of this market, as they are pivotal for treatment delivery and patient management, facilitating advanced procedures and providing access to specialized oncological care. The prevalence of cancer and the growing adoption of minimally invasive techniques significantly contribute to the demand in these settings.
Cancer Research Centers serve as critical hubs for innovation, focusing on clinical trials and the development of cutting-edge therapies, thereby fostering advancements that enhance treatment efficacy and patient outcomes. This segment is vital for cultivating new treatment modalities and improving clinical practices. Additionally, other healthcare facilities, including outpatient centers and specialty care providers, play an essential role in expanding the reach of transarterial chemoembolization, making it increasingly accessible to patients.Overall, the End User segment is driven by a rising incidence of liver cancer in South America, coupled with a healthcare shift towards integrated cancer treatment pathways.
Transarterial Chemoembolization Market Regional Insights
The South America Transarterial Chemoembolization Market is poised for steady growth, driven by increasing cancer incidences and a rising preference for minimally invasive procedures. Brazil, as the largest economy in the region, plays a critical role, often dominating the market owing to its advanced healthcare infrastructure and high demand for advanced cancer treatments.
Mexico also exhibits significant growth potential, supported by ongoing healthcare reforms and an increasing number of healthcare facilities adopting innovative treatment options.Argentina's market is influenced by a strong emphasis on patient-centered care, prioritizing effective treatment methodologies, while the Rest of South America encompasses various emerging markets that are gradually recognizing the importance of chemoembolization techniques. The overall market dynamics are shaped by the ongoing improvements in medical technologies, government initiatives promoting better healthcare access, and the need for efficient cancer therapy solutions.
Each region's unique healthcare policies and demographics contribute to the diverse landscape of the South America Transarterial Chemoembolization Market, highlighting opportunities for future advancements and expansions within this critical medical field.
 
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South America Transarterial Chemoembolization Market Key Players and Competitive Insights
The South America Transarterial Chemoembolization Market is a dynamic segment within the broader field of interventional oncology, which has witnessed significant advancements and interest in recent years. This market is characterized by its rapidly evolving landscape, driven by increasing incidences of liver cancers and the growing preference for minimally invasive treatment options among healthcare professionals and patients alike.
The competitive insights in this market reveal a multitude of players vying for a share, with a strong emphasis on innovation, product development, and strategic partnerships to enhance market penetration. These companies are continually evaluating their offerings to meet the diverse needs of healthcare providers and patients in South America, ensuring that they remain competitive amidst changing regulatory environments and technological advancements.
Boston Scientific has established a formidable presence in the South America Transarterial Chemoembolization Market through its innovative vascular and interventional products. The company's strengths lie in its robust research and development initiatives that focus on delivering high-quality solutions tailored for the treatment of liver tumors. By leveraging its extensive portfolio of minimally invasive tools and technologies, Boston Scientific is well-positioned to address the specific challenges faced by interventional radiologists in the region. Its commitment to training and education for healthcare professionals also underscores its competitive advantage, as this fosters deeper collaborations and strengthens its brand loyalty within the South American healthcare space.
AngioDynamics also plays a crucial role in the South America Transarterial Chemoembolization Market, with a product offering that includes specialized platforms for delivering localized cancer therapy. The company's strength is reflected in its innovative solutions designed for tumor embolization and intervention, which allow for effective treatment modalities in challenging scenarios. AngioDynamics has focused on expanding its market presence through strategic mergers and acquisitions, enhancing its capabilities and product offerings in the region.
By aligning with local distributors and investing in marketing efforts, the company has increased its visibility and accessibility in South American healthcare facilities. Through continuous innovation and relevant product differentiation, AngioDynamics seeks to capture a larger market share while addressing the unique needs of healthcare providers and patients within the region.
Key Companies in the South America Transarterial Chemoembolization Market Include:
South America Transarterial Chemoembolization Market Industry Developments
The South America Transarterial Chemoembolization Market has seen notable developments recently, particularly with firms like Boston Scientific, AngioDynamics, and Ipsen expanding their presence. In August 2023, Terumo Corporation announced a strategic partnership with local distributors to enhance market access for their transarterial chemoembolization products, targeting increased patient engagement across Brazil and Argentina.
Moreover, in July 2023, Medtronic successfully launched its latest embolization solutions in South America, specifically aiming to improve treatment protocols for liver cancer, reflecting a growing emphasis on liver-focused therapies in the region. The market is expected to benefit significantly from advancements in technology and the introduction of innovative products by major players like Bayer AG and Philips. In the past couple of years, SIRTex Medical made headlines by expanding its operations in Latin America, focusing on improving localized treatment options.
However, no significant merger or acquisition activity has been reported among the selected companies in this market in recent months. As the healthcare landscape evolves in South America, regulatory institutions are also reportedly looking to streamline processes for new treatments, fostering an environment conducive to market growth.
South America Transarterial Chemoembolization Market Segmentation Insights
Transarterial Chemoembolization Market Procedure Type Outlook
Transarterial Chemoembolization Market Indication Outlook
Transarterial Chemoembolization Market Product Type Outlook
Transarterial Chemoembolization Market End User Outlook
Transarterial Chemoembolization Market Regional Outlook
Brazil
Mexico
Argentina
Rest of South America
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 570.07(USD Million) |
| MARKET SIZE 2024 | 598.0(USD Million) |
| MARKET SIZE 2035 | 1012.29(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.902% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Boston Scientific, AngioDynamics, Ipsen, Terumo Corporation, Medtronic, Halyard Health, Bayer AG, Philips, SIRTex Medical, Cook Medical, Biodisciplinar, Siemens Healthineers, Johnson & Johnson, A. Menarini, Merit Medical Systems |
| SEGMENTS COVERED | Procedure Type, Indication, Product Type, End User, Regional |
| KEY MARKET OPPORTUNITIES | Growing prevalence of liver cancer, Increasing healthcare investments, Advancements in catheter technology, Rising demand for minimally invasive procedures, Expanding clinical trial opportunities |
| KEY MARKET DYNAMICS | increasing cancer prevalence, rising demand for minimally invasive procedures, advanced healthcare infrastructure, growing adoption of targeted therapies, expanding investment in R&D |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Frequently Asked Questions (FAQ) :
The South America Transarterial Chemoembolization Market is expected to be valued at 598.0 USD Million in 2024.
By 2035, the South America Transarterial Chemoembolization Market is expected to reach a value of 1012.29 USD Million.
The expected CAGR for the South America Transarterial Chemoembolization Market between 2025 and 2035 is 4.902%.
In 2024, Brazil is projected to lead the South America Transarterial Chemoembolization Market, valued at 200.0 USD Million.
The market value for the DEB-TACE procedure is forecasted to reach 441.84 USD Million by 2035.
The market size for Conventional TACE is expected to be 570.45 USD Million by 2035.
Major players include Boston Scientific, AngioDynamics, Ipsen, Terumo Corporation, and Medtronic among others.
In 2024, Mexico has the second highest market value in the region at 150.0 USD Million.
Argentina is valued at 100.0 USD Million in 2024 and is projected to reach 170.1 USD Million by 2035.
The market faces challenges of accessibility and regulation, while opportunities include advancements in technology and increasing cancer prevalence.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
